| No |
Title |
Journal |
First author |
Year |
WoS database total cited |
Times Cited in All Databases |
AS |
| 1 |
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline |
The Journal of Clinical Endocrinology & Metabolism |
Legro, Richard S |
2013 |
882 |
973 |
121 |
| 2 |
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications |
Endocrine Reviews |
Diamanti-Kandarakis, Evanthia |
2012 |
862 |
920 |
46 |
| 3 |
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. |
Fertility and Sterility |
Fauser, Bart CJM |
2012 |
854 |
926 |
58 |
| 4 |
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis |
Human Reproduction |
Bozdag, Gurkan |
2016 |
492 |
527 |
25 |
| 5 |
Epidemiology, diagnosis, and management of polycystic ovary syndrome |
Clinical Epidemiology |
Sirmans, Susan M. |
2014 |
478 |
506 |
157 |
| 6 |
Polycystic ovary syndrome |
Nature Reviews Disease primers |
Azziz, Ricardo |
2016 |
464 |
478 |
72 |
| 7 |
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. |
Endocrine Reviews |
Rosenfield, Robert L. |
2016 |
440 |
470 |
43 |
| 8 |
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. |
Nature Reviews Endocrinology |
Escobar-Morreale, Héctor F |
2018 |
436 |
476 |
44 |
| 9 |
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis |
Human Reproduction |
Lim, Siew S. |
2012 |
382 |
414 |
20 |
| 10 |
Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome |
Endocrine Reviews |
Dumesic, Daniel A |
2015 |
378 |
407 |
98 |
| 11 |
Criteria, prevalence, and phenotypes of polycystic ovary syndrome |
Fertility and Sterility |
Lizneva, Daria |
2016 |
362 |
400 |
65 |
| 12 |
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp |
Human Reproduction |
Stepto, Nigel K. |
2013 |
362 |
388 |
25 |
| 13 |
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome |
Nature Genetics |
Shi, Yongyong |
2012 |
359 |
383 |
5 |
| 14 |
Fresh versus frozen embryos for infertility in the polycystic ovary syndrome |
New England Journal of Medicine |
Chen, Zi-Jiang |
2016 |
351 |
395 |
281 |
| 15 |
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria |
Human Reproduction |
Yildiz, Bulent Okan |
2012 |
346 |
368 |
5 |
| 16 |
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome |
Human Reproduction |
Teede, Helena J. |
2018 |
334 |
359 |
60 |
| 17 |
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology |
European Journal of Endocrinology |
Conway, Gerard |
2014 |
332 |
377 |
9 |
| 18 |
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome |
New England Journal of Medicine |
Legro, Richard S |
2014 |
290 |
319 |
283 |
| 19 |
Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis |
Human Reproduction Update |
Murri, Mora |
2013 |
268 |
281 |
5 |
| 20 |
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis |
Obesity Reviews |
Lim, S. S. |
2013 |
265 |
287 |
28 |
| 21 |
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society |
Human Reproduction Update |
Dewailly, Didier |
2014 |
243 |
266 |
6 |
| 22 |
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. |
Human Reproduction Update |
Escobar-Morreale, H. F. |
2012 |
241 |
260 |
9 |
| 23 |
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis |
Human Reproduction Update |
Barry, John A |
2014 |
234 |
248 |
43 |
| 24 |
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. |
Cochrane Database of Systematic Reviews |
Tang, Thomas |
2012 |
232 |
236 |
0 |
| 25 |
Pregnancy complications in women with polycystic ovary syndrome |
Human Reproduction Update |
Palomba, Stefano |
2015 |
225 |
241 |
12 |
| 26 |
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. |
Human Reproduction Update |
Balen, Adam H. |
2016 |
223 |
246 |
38 |
| 27 |
Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction |
Steroids |
González, Frank |
2012 |
263 |
262 |
17 |
| 28 |
Prevalence of polycystic ovary syndrome in women in China: a large community-based study |
Human Reproduction |
Li, Rong |
2013 |
214 |
304 |
0 |
| 29 |
American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. |
Endocrine Practice |
Goodman, Neil F., |
2015 |
212 |
258 |
33 |
| 30 |
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 2. |
Endocrine Practice |
Goodman, Neil F., |
2015 |
204 |
230 |
6 |
| 31 |
Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo |
The Journal of Clinical Endocrinology & Metabolism |
Sang, Qing |
2013 |
203 |
226 |
7 |
| 32 |
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations |
Nature communications |
Hayes, M. Geoffrey |
2015 |
202 |
210 |
70 |
| 33 |
Rodent models for human polycystic ovary syndrome |
Biology of reproduction |
Walters, Kirsty A |
2012 |
201 |
211 |
2 |
| 34 |
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis |
Human Reproduction |
Cooney, Laura G. |
2017 |
196 |
200 |
10 |
| 35 |
Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. |
Human Reproduction Update |
Dewailly, Didier |
2016 |
194 |
207 |
1 |
| 36 |
The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage |
The Journal of Clinical Endocrinology & Metabolism |
Roger Hart |
2015 |
189 |
203 |
67 |
| 37 |
Polycystic ovary syndrome |
New England Journal of Medicine |
McCartney, Christopher R. |
2016 |
188 |
205 |
157 |
| 38 |
Cardiometabolic aspects of the polycystic ovary syndrome. |
Endocrine Reviews |
Randeva, Harpal S |
2012 |
178 |
184 |
3 |
| 39 |
Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome |
Nature communications |
Day, Felix R |
2015 |
172 |
177 |
136 |
| 40 |
Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione |
The Journal of Clinical Endocrinology & Metabolism |
O’Reilly, Michael W. |
2014 |
172 |
185 |
15 |
| 41 |
Can anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data |
The Journal of Clinical Endocrinology & Metabolism |
Iliodromiti, Stamatina |
2013 |
172 |
185 |
3 |
| 42 |
Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women |
Obesity |
Teede, Helena J. |
2013 |
170 |
183 |
35 |
| 43 |
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis |
Human Reproduction Update |
Naderpoor, Negar |
2015 |
169 |
180 |
34 |
| 44 |
Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood |
Nature medicine |
Tata, Brooke |
2018 |
168 |
177 |
415 |
| 45 |
miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance |
Diabetes |
Chen, Yen-Hao |
2013 |
164 |
181 |
29 |
| 46 |
Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis |
Reproductive Biology and Endocrinology |
Qin, Jun Z. |
2013 |
164 |
176 |
11 |
| 47 |
Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models |
Endocrinology |
Caldwell, A. S. L |
2014 |
160 |
172 |
0 |
| 48 |
Is PCOS an inflammatory process? |
Fertility and Sterility |
Duleba, Antoni J. |
2012 |
159 |
165 |
16 |
| 49 |
Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome |
Reproduction |
Spritzer, Poli Mara |
2015 |
158 |
174 |
2 |
| 50 |
Vitamin D in the aetiology and management of polycystic ovary syndrome. |
Clinical endocrinology |
Thomson, Rebecca L. |
2012 |
156 |
169 |
8 |
| 51 |
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Müllerian hormone. |
Human Reproduction |
Lauritsen, M. P. |
2014 |
152 |
167 |
15 |
| 52 |
Genetic, hormonal and metabolic aspects of PCOS: an update |
Reproductive Biology and Endocrinology |
De Leo, V. |
2016 |
151 |
165 |
10 |
| 53 |
Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. |
Nature medicine |
Qi, Xinyu |
2019 |
149 |
166 |
136 |
| 54 |
Sheep models of polycystic ovary syndrome phenotype |
Molecular and cellular endocrinology |
Padmanabhan, Vasantha |
2013 |
146 |
149 |
3 |
| 55 |
Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria |
PLoS genetics |
Day, Felix |
2018 |
145 |
148 |
218 |
| 56 |
Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance |
The Journal of Clinical Endocrinology & Metabolism |
Jones, Helen |
2012 |
141 |
147 |
8 |
| 57 |
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study |
Diabetes |
Gambineri, Alessandra |
2012 |
141 |
146 |
62 |
| 58 |
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies |
Human Reproduction |
Cassar, Samantha |
2016 |
139 |
149 |
2 |
| 59 |
The diagnosis of polycystic ovary syndrome during adolescence |
Hormone research in paediatrics |
Witchel, Selma F. |
2015 |
136 |
141 |
10 |
| 60 |
An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence |
Hormone research in paediatrics |
Ibáñez, Lourdes |
2017 |
135 |
141 |
21 |
| 61 |
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome |
The Journal of Clinical Endocrinology & Metabolism |
Moghetti, Paolo |
2013 |
135 |
138 |
2 |
| 62 |
Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome |
The Journal of Clinical Endocrinology & Metabolism |
Gibson-Helm, Melanie |
2017 |
129 |
133 |
322 |
| 63 |
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts |
Journal of medical genetics |
Goodarzi, Mark O |
2012 |
127 |
135 |
4 |
| 64 |
Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome |
Frontiers in Microbiology |
Liu, Rui |
2017 |
126 |
144 |
17 |
| 65 |
Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. |
PloS one |
Lindheim, Lisa |
2017 |
126 |
153 |
48 |
| 66 |
11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome |
The Journal of Clinical Endocrinology & Metabolism |
O’Reilly, Michael W. |
2017 |
125 |
126 |
25 |
| 67 |
Metabolic risk in PCOS: phenotype and adiposity impact. |
Trends in Endocrinology & Metabolism |
Moran, Lisa J |
2015 |
124 |
133 |
3 |
| 68 |
Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial |
The Journal of Clinical Endocrinology & Metabolism |
Morin-Papunen, Laure |
2012 |
123 |
133 |
9 |
| 69 |
Polycystic Ovary Syndrome |
Obstetrics & Gynecology |
Azziz, Ricardo MD, MPH |
2018 |
120 |
134 |
8 |
| 70 |
The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis |
Oncotarget |
Ding, Tao |
2017 |
120 |
134 |
24 |
| 71 |
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype |
Proceedings of the National Academy of Sciences of the United States of America |
McAllister, Jan M. |
2014 |
120 |
150 |
28 |
| 72 |
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? |
Fertility and Sterility |
Daan, Nadine MP |
2014 |
120 |
131 |
10 |
| 73 |
Evaluating the association between endometrial cancer and polycystic ovary syndrome |
Human Reproduction |
Haoula, Zeina |
2012 |
119 |
133 |
7 |
| 74 |
Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy |
Journal of steroid biochemistry and molecular biology |
Patel, S |
2018 |
118 |
126 |
5 |
| 75 |
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility |
Cochrane Database of Systematic Reviews |
Morley, Lara C. |
2017 |
118 |
124 |
0 |
| 76 |
Placental steroidogenesis in pregnant women with polycystic ovary syndrome |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
Maliqueo, Manuel |
2013 |
117 |
120 |
0 |
| 77 |
Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome |
Journal of assisted reproduction and genetics |
Roth, Lauren W |
2014 |
115 |
127 |
6 |
| 78 |
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis |
BMC medicine |
Zhao, Yue |
2012 |
115 |
127 |
11 |
| 79 |
Roles of oxidative stress in polycystic ovary syndrome and cancers |
Oxidative medicine and cellular longevity |
Zuo, Tao |
2016 |
114 |
123 |
1 |
| 80 |
Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis |
The Journal of Clinical Endocrinology & Metabolism |
Domecq, Juan Pablo |
2013 |
113 |
118 |
3 |
| 81 |
Cancer risk and PCOS |
Steroids |
Dumesic, Daniel A. |
2013 |
113 |
124 |
33 |
| 82 |
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines |
Journal of the Academy of Nutrition and Dietetics |
Moran, Lisa J. |
2013 |
113 |
116 |
106 |
| 83 |
Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies |
Human Reproduction Update |
Veltman-Verhulst, Susanne M. |
2012 |
112 |
113 |
9 |
| 84 |
Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression |
The Journal of Clinical Endocrinology & Metabolism |
Murri, Mora |
2013 |
111 |
118 |
3 |
| 85 |
Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.” |
Gynecological Endocrinology |
Unfer, Vittorio |
2012 |
111 |
120 |
8 |
| 86 |
Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression |
Human Reproduction Update |
Kakoly, N. S. |
2018 |
109 |
121 |
0 |
| 87 |
Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism |
The Journal of Clinical Endocrinology & Metabolism |
Torres, Pedro J. |
2018 |
109 |
124 |
153 |
| 88 |
Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry |
The Journal of Clinical Endocrinology & Metabolism |
Welt, Corrine K |
2012 |
108 |
115 |
1 |
| |
|
|
|
|
|
|
|
| 89 |
Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity |
International journal of environmental research and public health |
Wolf, Wendy M. |
2018 |
107 |
108 |
118 |
| 90 |
Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome |
Proceedings of the National Academy of Sciences of the United States of America |
Moore, Aleisha M. |
2015 |
107 |
110 |
4 |
| 91 |
Reproductive and Metabolic Phenotype of a Mouse Model of PCOS |
Endocrinology |
Leonie, E. |
2012 |
107 |
107 |
3 |
| 92 |
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis |
Human Reproduction Update |
Meyer, Michelle L. |
2012 |
106 |
109 |
8 |
| 93 |
Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis |
Nutrients |
He, Chunla |
2015 |
104 |
113 |
17 |
| 94 |
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis |
Fertility and Sterility |
Dokras, Anuja |
2012 |
104 |
117 |
42 |
| 95 |
Association between polycystic ovary syndrome and the risk of pregnancy complications |
Medicine |
Yu, Hai-Feng |
2016 |
103 |
107 |
4 |
| 96 |
Dysbiosis of Gut Microbiota (DOGMA) – A novel theory for the development of Polycystic Ovarian Syndrome |
Medical hypotheses |
Tremellen, Kelton |
2012 |
103 |
127 |
30 |
| 97 |
In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes |
Human Reproduction |
Walls, M. L. |
2015 |
102 |
105 |
25 |
| 98 |
In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case–control study of 194 treatment cycles. |
Fertility and Sterility |
Gremeau, Anne-Sophie |
2012 |
102 |
104 |
56 |
| 99 |
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome |
Cochrane Database of Systematic Reviews |
Farquhar, Cindy |
2012 |
102 |
108 |
0 |
| 100 |
Poly Cystic Ovarian Syndrome: An Updated Overview |
Frontiers in physiology |
El Hayek, Samer |
2016 |
100 |
110 |
15 |
Source
